Recalls / Brands / Lanreotide Acetate
Lanreotide Acetate
1 FDA drug recall involving brand “Lanreotide Acetate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2026-01-02 | Class II | Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, | Cipla USA, Inc. |